Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid pulse therapy for advanced tertiary lymphoid tissues after kidney transplantation
jRCT1051210189Active, not recruiting
- Start
- May 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of methylprednisolone in Kidney transplant complication. Primary endpoint: Change in tertiary lymphoid tissues. Started May 2022; status: active, not recruiting.
02
Drugs
methylprednisolone
03
Conditions
Kidney transplant complication
Beyond the preview
Go deeper on jRCT1051210189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051210189.